Research
2006
501-1000 Employees
Vall d’Hebron Institut d’Oncologia (VHIO)The Vall d’Hebron Institute of Oncology (VHIO) promotes and carries out first-class research into methods for improving the prevention, early diagnosis and treatment of cancer.
To achieve this goal, its strategy focuses on developing innovative programmes of clinical, basic and translational research with a model based on the best international research centres.
Clinical research is at the heart of its scientific activities, making it a driving force and inspiration behind the development of basic and translational research programmes. This approach means research results from the laboratory can be quickly and effectively applied to patient care, encouraging the development of connections between the needs of patients and doctors and basic research programmes.
To achieve this goal, its strategy focuses on developing innovative programmes of clinical, basic and translational research with a model based on the best international research centres.
Clinical research is at the heart of its scientific activities, making it a driving force and inspiration behind the development of basic and translational research programmes. This approach means research results from the laboratory can be quickly and effectively applied to patient care, encouraging the development of connections between the needs of patients and doctors and basic research programmes.
Address
Carrer de Natzaret 115, 08035 Barcelona, Spain
Institution contacts for TechTransfer & Innovation
MD
Mario De la Cuesta Rivero
Vall d’Hebron Institut d’Oncologia (VHIO)Participated Spin-Offs
Barcelona, Spain
2013
MOSAIC BIOMEDICALS SL
Barcelona, Spain
2021
ONIRIA THERAPEUTICS SL
Barcelona, Spain
2014
PEPTOMYC SL
Barcelona, Spain
2020
REVEAL GENOMICS SL
Main Domain of Research
Research Domain
Sustainable Development Goals (SDG)
Objectius de Desenvolupament Sostenible (ODS)Sustainable Development Goals (SDG)
*English name. Acronym
Acronim
VHIO